# Catheter Precision, Inc. (VTAK)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Market cap:** $2M  
**Price:** $1.10 (+10.00%)

> Catheter Precision, Inc. is a dynamic player in the medical technology sector, specializing in the development and commercialization of advanced catheters and related technologies. The company focuses on providing innovative solutions for electrophysiology, a branch of cardiology that examines and treats arrhythmias. Their products are designed to support physicians in diagnosing and treating heart rhythm disorders with precision and efficacy. Notable features of Catheter Precision’s offerings include cutting-edge technology that enhances the accuracy of cardiac interventions and improves patient outcomes. As part of the broader healthcare sector, the company contributes to advancing medical treatments and has a significant impact on the quality of care provided to patients with cardiac issues. By continually innovating and integrating state-of-the-art technologies, Catheter Precision plays a crucial role in the electrophysiology market, offering tools that empower healthcare professionals to deliver superior cardiac care.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $819,000 | $756,000 | -$21M | -$17M | — |
| 2024 | $420,000 | $378,000 | -$11M | -$17M | — |
| 2023 | $442,000 | $412,000 | -$78M | -$71M | — |
| 2022 | $14,000 | -$147,000 | -$27M | -$27M | — |
| 2021 | $22,000 | -$2M | -$29M | -$25M | — |
| 2020 | $259,000 | -$2M | -$35M | -$36M | — |
| 2019 | $7M | -$2M | -$58M | -$57M | — |
| 2018 | $6M | $2M | -$31M | -$31M | — |
| 2017 | $6M | $2M | -$18M | -$18M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $16M | $9M | $7M | $88,000 | $3M |
| 2024 | $28M | $16M | $12M | $3M | — |
| 2023 | $31M | $10M | $21M | $4M | — |
| 2022 | $17M | $8M | $9M | $16M | — |
| 2021 | $21M | $7M | $14M | $15M | — |
| 2020 | $33M | $12M | $21M | $24M | — |
| 2019 | $44M | $11M | $33M | $15M | $558,000 |
| 2018 | $74M | $7M | $67M | $64M | $850,000 |
| 2017 | $11M | $19M | -$8M | $8M | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | -$8M | $17,000 | -$8M |
| 2024 | -$9M | $67,000 | -$9M |
| 2023 | -$21M | $76,000 | -$21M |
| 2022 | -$23M | $17,000 | -$23M |
| 2021 | -$28M | $265,000 | -$28M |
| 2020 | -$28M | $67,000 | -$28M |
| 2019 | -$33M | $268,000 | -$33M |
| 2018 | -$19M | $582,000 | -$19M |
| 2017 | -$6M | $547,000 | -$6M |

Source: [CompaniesByCap](https://companiesbycap.com/company/VTAK)